[Zinc aspartate treatment of pneumoconiosis].
Petrova
E
E
Nachev
Ch
Ch
Aleksiev
N
N
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D001195:Asbestosis / Q000188:drug therapy; D001224:Aspartic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D011009:Pneumoconiosis / Q000150:complications / Q000188:drug therapy*; D012829:Silicosis / Q000188:drug therapy; D013997:Time Factors; D017967:Zinc Compounds / Q000008:administration & dosage / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D000975:Antioxidants; D017967:Zinc Compounds; D001224:Aspartic Acid